These are the top 10 jobs in the US for 2026, according to Indeed

Indeed’s 2026 Best Jobs ranking—based on pay, immediate demand, wage growth, hiring momentum and remote flexibility—is dominated by healthcare roles: cardiac medical tech tops the list (median annual pay $133,907; 34% wage growth and 34% postings growth), with nurse practitioner ($143,183) and several therapy and counseling roles also highly ranked. Non-healthcare entries include truck driver owner-operator (median $160,000; postings growth 39%) and data scientist ($115,079; 35% remote), revealing mixed wage trends across occupations. The report highlights that healthcare accounted for 72% of recent job growth despite representing only 11% of jobs, while broader labor market momentum is cooling (50,000 jobs added in December vs. 60,000 expected), signalling sector-specific resilience amid a softer macro hiring backdrop.

Analysis

Winners: healthcare staffing firms, specialist clinicians, and med‑tech suppliers should see persistent demand — Indeed finds healthcare = 72% of recent job growth despite being 11% of jobs, implying structural undercapacity. Expect firms that control placement (AMN) and capital goods for therapy/radiation (large med‑tech OEMs) to extract pricing power over 6–24 months.

Competitive dynamics and supply/demand: steep wage growth in niches (cardiac tech +34%, radiation therapy +26%) signals tight labor markets and upward unit labor costs in hospital services; by contrast truck owner‑operator postings +39% with wage growth −5% implies increased supply/fragmentation in trucking, pressuring spot rates. Data scientists show postings +15% but wages −3%, indicating oversupply and margin pressure for pure analytics shops within 3–12 months.

Cross‑asset implications: persistent healthcare wage inflation supports services CPI and real yields (pushes 10‑yr up ~10–30bp probability if trend continues), favoring short duration/TIPS and USD strength; diesel demand steadies trucking capex and oil refining margins marginally. Equity winners should be healthcare staffing/med‑tech; implied vol may rise into hospital earnings and CMS rule dates, creating option opportunities in Jan–Jun windows.

Risks & catalysts: tail risks include Medicare/Medicaid reimbursement cuts (6–12 month regulatory window), faster AI adoption displacing routine analytics/teletherapy (12–36 months), and a macro slowdown that chokes elective care (next 3–9 months). Monitor CMS rule releases, hospital M&A, and Fed communications — any of which can accelerate or reverse sector flows quickly.

Key Decisions for Investors

• Establish a 2–3% portfolio long in AMN Healthcare Services (AMN) over the next 4 weeks; use a 6‑month 5% ITM call / 25% OTM call credit spread to express upside while capping premium — target +20% in 12 months if staffing demand persists.
• Add a 2–3% defensive healthcare equity position in UnitedHealth Group (UNH) via a 12‑month 2.5% OTM call purchase financed by selling 3‑month calls (calendar); this expresses ~15% upside expectation over 9–12 months while collecting near‑term premium to reduce cost.
• Take a 1.5–2% exposure to truck OEMs via PACCAR (PCAR) or Knight‑Swift (KNX) over the next 1–3 months to play owner‑operator capex and spot freight volatility; size modestly and set stop‑loss at −12% due to cyclic risk.
• Increase allocation to short‑duration inflation hedges: move 4–6% into VTIP (0–5yr TIPS ETF) within 2 weeks to hedge services‑driven inflation risk; concurrently, monitor CMS reimbursement rule publications over the next 90 days — if cuts >2% implied, reduce UNH/AMN exposure by 50%.